https://www.selleckchem.com/pr....oducts/Nicotinamide(
nally, the protein and gene expression levels of β3-AR, PPAR-α, and mCPT-1 were increased in the HFD + β3-AGO group, whereas those of PPAR-γ and FAT/CD36 were decreased. Conclusion The β3-AR agonist BRL37344 is beneficial for reducing liver fat accumulation and for ameliorating liver steatosis and inflammation in NAFLD. These effects may be associated with PPARs/mCPT-1 and FAT/CD36.Background Several previous studies have reported a cross-sectional association between elevated high sensitivity C-reactive protein (hs-CR
Like
Comment
Share
